e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diagnosis and management of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy
I. Ivancsó, N. Eszes, G. Beko, A. Bohács, G. Toldi, J. Rigó, Jr., G. Losonczy, B. Vásárhelyi, L. Tamási (Budapest, Hungary)
Source:
Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session:
Diagnosis and management of respiratory diseases
Session type:
Thematic Poster Session
Number:
4166
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Ivancsó, N. Eszes, G. Beko, A. Bohács, G. Toldi, J. Rigó, Jr., G. Losonczy, B. Vásárhelyi, L. Tamási (Budapest, Hungary). Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy. Eur Respir J 2013; 42: Suppl. 57, 4166
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Assessment of serum magnesium level in patients with bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Fatty acid blood spectrum in patients with asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Free serum IL-18 levels and responsiveness to omalizumab in patients with severe asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
YKL-40 levels in cord blood – Associations with respiratory symptoms and asthma in children?
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015
Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Simultaneously increased serum periostin and urinary EDN relates to reduced lung function in adults with asthma from the Swedish GA2LEN study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Serum periostin but not airway
POSTN
expression is reduced in smokers with asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept